ijms-logo

Journal Browser

Journal Browser

The Functional Impact of DNA Repair Gene Variants in Breast and Ovarian Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 2585

Special Issue Editor


E-Mail Website
Guest Editor
Yeast Genetics and Genomics Group, Laboratory of Functional Genetics and Genomics, Institute of Clinical Physiology CNR, Via Moruzzi 1, 56125 Pisa, Italy
Interests: homologous recombination; yeast functional assays; genome wide screening; cancer genetics; BRCA1 variant classification
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Germline mutations in the DNA double strand break (DSB) and Mismatch repair genes have been reported to increase lifetime risk of developing hereditary breast and/or ovarian cancer (HBOC). With new sequencing technologies, numerous variants of uncertain significance (VUS) are identified. It is mandatory to develop new tools to evaluate the functional impact of VUS and its pathogenicity. Cancer-causing mutations in the coding sequence of these genes are expected to impair the protein’s biological activity; precisely, a protein-truncating mutation is more likely to be pathogenic as compared to missense variants that need to be studied in “reliable” functional assays in order to establish their pathogenicity. For instance, the pleiotropic nature of these proteins and the presence of several domains complicates the interpretation of functional data because it is not established which of its functions are important for tumor suppression. The availability of functional assays could be of great help in the assessment of cancer risk and can contribute to understanding the mechanism of tumorigenesis. In addition, the biological validity of a functional assay should be assessed by determining to what extent the assay relies on a natural function of the protein, and how this particular function contributes to tumor suppression. While we have strong evidence that functions interrogated in the assays are bona fide functions of these proteins, evidence that a certain function is required or even contributory to its tumor suppression activity has been difficult to demonstrate. The Special Issue “The Functional Impact of DNA Repair Gene Variants in Breast and Ovarian Cancer” will provide a new platform aiming to collect original articles and reviews that will contribute to elucidating the mechanism of tumorigenesis through molecular and genetic studies. Original studies evaluating the functional impact of variants in DSB repair genes at the molecular level and contributing to identifying new functional interactors will be accepted.

Dr. Alvaro Galli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor suppressors
  • breast and ovarian cancer
  • cancer-associated variants
  • DNA double strand break repair
  • mismatch repair
  • functional assays

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1672 KiB  
Article
Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants
by Francesca Bellè, Alberto Mercatanti, Samuele Lodovichi, Caterina Congregati, Chiara Guglielmi, Mariella Tancredi, Maria Adelaide Caligo, Tiziana Cervelli and Alvaro Galli
Int. J. Mol. Sci. 2022, 23(7), 4049; https://doi.org/10.3390/ijms23074049 - 06 Apr 2022
Cited by 3 | Viewed by 2090
Abstract
Germline mutations in the BRCA1 gene have been reported to increase the lifetime risk of developing breast and/or ovarian cancer (BOC). By new sequencing technologies, numerous variants of uncertain significance (VUS) are identified. It is mandatory to develop new tools to evaluate their [...] Read more.
Germline mutations in the BRCA1 gene have been reported to increase the lifetime risk of developing breast and/or ovarian cancer (BOC). By new sequencing technologies, numerous variants of uncertain significance (VUS) are identified. It is mandatory to develop new tools to evaluate their functional impact and pathogenicity. As the expression of pathogenic BRCA1 variants in Saccharomyces cerevisiae increases the frequency of intra- and inter-chromosomal homologous recombination (HR), and gene reversion (GR), we validated the two HR and the GR assays by testing 23 benign and 23 pathogenic variants and compared the results with those that were obtained in the small colony phenotype (SCP) assay, an additional yeast-based assay, that was validated previously. We demonstrated that they scored high accuracy, sensitivity, and sensibility. By using a classifier that was based on majority of voting, we have integrated data from HR, GR, and SCP assays and developed a reliable method, named yBRCA1, with high sensitivity to obtain an accurate VUS functional classification (benign or pathogenic). The classification of BRCA1 variants, important for assessing the risk of developing BOC, is often difficult to establish with genetic methods because they occur rarely in the population. This study provides a new tool to get insights on the functional impact of the BRCA1 variants. Full article
Show Figures

Figure 1

Back to TopTop